Erythropoietin in the treatment of carbon monoxide neurotoxicity in rat

Food and Chemical Toxicology

Volumn 86, Issue , 2015, Pages 56-64

  Moallem, Seyed Adel ^a,b,c   Mohamadpour, Amir Hooshang ^a,b   Abnous, Khalil ^a,b   Sankian, Mojtaba ^d   Sadeghnia, Hamid Reza ^a   Tsatsakis, Aristidis ^e   Shahsavand, Shabnam ^a,f  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e UNIVERSITY OF CRETE   (Greece)

^f NORTH KHORASAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Carbon monoxide poisoning; Erythropoietin; Glial fibrillary acidic protein; Myelin basic protein; Myeloperoxidase; Neurotoxicity

Indexed keywords

CARBON MONOXIDE; EVANS BLUE; GLIAL FIBRILLARY ACIDIC PROTEIN; MALONALDEHYDE; MYELIN BASIC PROTEIN; MYELOPEROXIDASE; PROTEIN BAX; PROTEIN BCL 2; RECOMBINANT ERYTHROPOIETIN; ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN WATER; CELL VACUOLE; CONTROLLED STUDY; DEMYELINATION; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVITY; EXTRAVASATION; ION EXCHANGE CHROMATOGRAPHY; LIPID PEROXIDATION; MALE; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; STAINING; ANIMAL; BRAIN; CARBON MONOXIDE POISONING; CENTRAL NERVOUS SYSTEM DISEASES; CHEMICALLY INDUCED; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; RANDOMIZATION; WISTAR RAT;

ANIMALS; BCL-2-ASSOCIATED X PROTEIN; BLOOD-BRAIN BARRIER; BRAIN; CARBON MONOXIDE; CARBON MONOXIDE POISONING; CENTRAL NERVOUS SYSTEM DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROPOIETIN; GENE EXPRESSION REGULATION; LIPID PEROXIDATION; MALE; MYELIN BASIC PROTEIN; PROTO-ONCOGENE PROTEINS C-BCL-2; RANDOM ALLOCATION; RATS; RATS, WISTAR;

EID: 84943244779     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2015.09.015     Document Type: Article

References (57)

1. Agnello D., Bigini P., Villa P., Mennini T., Cerami A., Brines M.L., et al. Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis. Brain Res. 2002, 952(1):128-134.
2. Alonso J.R., Cardellach F., Lopez S., Casademont J., Miro O. Carbon monoxide specifically inhibits cytochrome C oxidase of human mitochondrial respiratory chain. Pharmacol. Toxicol. 2003, 93(3):142-146.
3. Banks W.A., Jumbe N.L., Farrell C.L., Niehoff M.L., Heatherington A.C. Passage of erythropoietic agents across the blood-brain barrier: a comparison of human and murine erythropoietin and the analog darbepoetin alfa. Eur. J. Pharmacol. 2004, 505(1-3):93-101.
4. Benes F.M. Emerging principles of altered neural circuitry in schizophrenia. Brain Res. Rev. 2000, 31(2-3):251-269.
5. Bernaudin M., Bellail A., Marti H.H., Yvon A., Vivien D., Duchatelle I., et al. Neurons and astrocytes express EPO mRNA: oxygen-sensing mechanisms that involve the redox-state of the brain. GLIA 2000, 30(3):271-278.
6. Brines M.L., Ghezzi P., Keenan S., Agnello D., De Lanerolle N.C., Cerami C., et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc. Natl. Acad. Sci. U. S. A. 2000, 97(19):10526-10531.
7. Calapai G., Marciano M.C., Corica F., Allegra A., Parisi A., Frisina N., et al. Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation. Eur. J. Pharmacol. 2000, 401(3):349-356.
8. Cervellini I., Annenkov A., Brenton T., Chernajovsky Y., Ghezzi P., Mengozzi M. Erythropoietin (EPO) increases myelin gene expression in CG4 oligodendrocyte cells through the classical EPO receptor. Mol. Med. 2013, 19:223-229. Epub 2013/07/04.
9. Cho Y.K., Kim G., Park S., Sim J.H., Won Y.J., Hwang C.H., et al. Erythropoietin promotes oligodendrogenesis and myelin repair following lysolecithin-induced injury in spinal cord slice culture. Biochem. Biophys. Res. Commun. 2012, 417(2):753-759.
10. Choi I.S. Delayed neurologic sequelae in carbon monoxide intoxication. Arch. Neurol. 1983, 40(7):433-435.
11. 2-limited heme degradation in the rat brain. Free Radic. Biol. Med. 2004, 37(11):1802-1812.
12. Delanty N., Needell N. Erythropoietin and visual hallucinations in patients on dialysis. Psychosomatics 1998, 39(1):83-85.
13. Garland H., Pearce J. Neurological complications of carbon monoxide poisoning. Q. J. Med. 1967, 36(144):445-455.
14. Genc K., Genc S., Baskin H., Semin I. Erythropoietin decreases cytotoxicity and nitric oxide formation induced by inflammatory stimuli in rat oligodendrocytes. Physiol. Res. 2006, 55(1):33-38.
15. Guan L., Wen T., Zhang Y., Wang X., Zhao J. Induction of heme oxygenase-1 with hemin attenuates hippocampal injury in rats after acute carbon monoxide poisoning. Toxicology 2009, 262(2):146-152.
16. Gunnarson E., Song Y., Kowalewski J.M., Brismar H., Brines M., Cerami A., et al. Erythropoietin modulation of astrocyte water permeability as a component of neuroprotection. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(5):1602-1607.
17. Herman J.P., Watson S.J. The Rat Brain in Stereotaxic Coordinates 1986, vol. 10(10):439. Academic Press, £40.00/$80.00 (264 pages) ISBN 012 547 6213. Trends in Neurosciences. 1987. second ed.
18. Hosseinzadeh H., Parvardeh S., Asl M.N., Sadeghnia H.R., Ziaee T. Effect of thymoquinone and Nigella sativa seeds oil on lipid peroxidation level during global cerebral ischemia-reperfusion injury in rat hippocampus. Phytomedicine 2007, 14(9):621-627.
19. Iencean S.M. Brain edema - a new classification. Med. Hypotheses 2003, 61(1):106-109.
20. Iwai M., Stetler R.A., Xing J., Hu X., Gao Y., Zhang W., et al. Enhanced oligodendrogenesis and recovery of neurological function by erythropoietin after neonatal Hypoxic/Ischemic brain injury. Stroke 2010, 41(5):1032-1037.
21. Kaneko N., Kako E., Sawamoto K. Enhancement of ventricular-subventricular zone-derived neurogenesis and oligodendrogenesis by erythropoietin and its derivatives. Front. Cell. Neurosci. 2013, 7:235. Epub 2013/12/19.
22. Koyama J., Miyake S., Sasayama T., Kondoh T., Kohmura E. Effect of VEGF receptor antagonist (VGA1155) on brain edema in the rat cold injury model. Kobe J. Med. Sci. 2007, 53(5):199-207.
23. Laas R., Igloffestein J., Meyerhoff S. Cerebral infarction due to carotid occlusion and carbon monoxide exposure: I. Pathophysiological and neuropathological investigations. J. Neurol. Neurosurg. Psychiatry 1983, 46:756-767.
24. Lee H.M., Greeley G.H., Herndon D.N., Sinha M., Luxon B.A., Englander E.W. A rat model of smoke inhalation injury: influence of combustion smoke on gene expression in the brain. Toxicol. Appl. Pharmacol. 2005, 208(3):255-265.
25. Li Y., Hu X., Lu Z. Erythropoietin in the treatment of encephalopathy associated with carbon monoxide poisoning. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2009, 33(4):735-738.
26. Martínez-Estrada O.M., Rodríguez-Millán E., González-de Vicente E., Reina M., Vilaró S., Fabre M. Erythropoietin protects the in vitro blood-brain barrier against VEGF-induced permeability. Eur. J. Neurosci. 2003, 18(9):2538-2544.
27. Meng Q.Y., Wang W., Chen X.N., Xu T.L., Zhou J.N. Distribution of acid-sensing ion channel 3 in the rat hypothalamus. Neuroscience 2009, 159(3):1126-1134.
28. Min S.K. A brain syndrome associated with delayed neuropsychiatric sequelae following acute carbon monoxide intoxication. Acta Psychiatr. Scand. 1986, 73(1):80-86.
29. Myers R.A., Snyder S.K., Emhoff T.A. Subacute sequelae of carbon monoxide poisoning. Ann. Emerg. Med. 1985, 14(12):1163-1167.
30. Öztürk E., Demirbilek S., Köroğlu A., But A., Begeç ZÖ Gülec M., et al. Propofol and erythropoietin antioxidant properties in rat brain injured tissue. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2008, 32(1):81-86.
31. Pan H.C., Kao T.K., Ou Y.C., Yang D.Y., Yen Y.J., Wang C.C., et al. Protective effect of docosahexaenoic acid against brain injury in ischemic rats. J. Nutr. Biochem. 2009, 20(9):715-725.
32. Pang L., Bian M., Zang X.X., Wu Y., Xu D.H., Dong N., et al. Neuroprotective effects of erythropoietin in patients with carbon monoxide poisoning. J. Biochem. Mol. Toxicol. 2013, 27(5):266-271. Epub 2013/04/05.
33. Pelinka L.E., Kroepfl A., Schmidhammer R., Krenn M., Buchinger W., Redl H., et al. Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma. J. Trauma 2004, 57(5):1006-1012.
34. Piantadosi C.A. Toxicity of carbon monoxide: hemoglobin vs. histotoxic mechanisms. Carbon Monoxide 1996, 163-186.
35. Piantadosi C.A., Zhang J., Levin E.D., Folz R.J., Schmechel D.E. Apoptosis and delayed neuronal damage after carbon monoxide poisoning in the rat. Exp. Neurol. 1997, 147(1):103-114.
36. Rabie T., Marti H.H. Brain Protection by erythropoietin: a Manifold task. Physiology 2008, 23(5):263-274.
37. Robach P., Recalcati S., Girelli D., Campostrini N., Kempf T., Wollert K.C., et al. Serum hepcidin levels and muscle iron proteins in humans injected with low- or high-dose erythropoietin. Eur. J. Haematol. 2013, 91(1):74-84. Epub 2013/04/16.
38. Rooney T., Edwards C.K., Gogarty M., Greenan L., Veale D.J., FitzGerald O., et al. Synovial tissue rank ligand expression and radiographic progression in rheumatoid arthritis: observations from a proof-of-concept randomized clinical trial of cytokine blockade. Rheumatol. Int. Nov 2010, 30(12):1571-1580. Epub 2009/09/22.
39. Sakanaka M., Wen T.C., Matsuda S., Masuda S., Morishita E., Nagao M., et al. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc. Natl. Acad. Sci. U. S. A. 1998, 95(8):4635-4640.
40. Sattler M.B., Merkler D., Maier K., Stadelmann C., Ehrenreich H., Bahr M., et al. Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis. Cell Death Differ. 2004, 11(S2):S181-S192.
41. Shahsavand S., Mohammadpour A.H., Rezaee R., Behravan E., Sakhtianchi R., Moallem S.A. Effect of erythropoietin on serum brain-derived biomarkers after carbon monoxide poisoning in rats. Iran. J. Basic Med. Sci. 2012, 15(2):752-758.
42. Shin T., Ahn M., Moon C., Kim S. Erythropoietin and autoimmune neuroinflammation: lessons from experimental autoimmune encephalomyelitis and experimental autoimmune neuritis. Anat. Cell Biol. 2012, 45(4):215-220. Epub 2013/01/10.
43. Shingo T., Todd Sorokan S., Shimazaki T., Weiss S. Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J. Neurosci. 2001, 21(24):9733-9743.
44. Siren A.L., Knerlich F., Poser W., Gleiter C.H., Bruck W., Ehrenreich H. Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol. (Berl.) 2001, 101(3):271-276.
45. Stocchetti N., Colombo A., Ortolano F., Videtta W., Marchesi R., Longhi L., et al. Time course of intracranial hypertension after traumatic brain injury. J. Neurotrauma 2007, 24(8):1339-1346.
46. Stocchetti N., Zanaboni C., Colombo A., Citerio G., Beretta L., Ghisoni L., et al. Refractory intracranial hypertension and "second-tier" therapies in traumatic brain injury. Intensive Care Med. 2008, 34(3):461-467.
47. Thom S.R., Keim L.W. Carbon monoxide poisoning: a review epidemiology, pathophysiology, clinical findings, and treatment options including hyperbaric oxygen therapy. J. Toxicol. Clin. Toxicol. 1989, 27(3):141-156.
48. Thom S.R., Bhopale V.M., Han S.T., Clark J.M., Hardy K.R. Intravascular neutrophil activation due to carbon monoxide poisoning. Am. J. Respir. Crit. Care Med. 2006, 174(11):1239-1248.
49. Thom S.R., Bhopale V.M., Fisher D. Hyperbaric oxygen reduces delayed immune-mediated neuropathology in experimental carbon monoxide toxicity. Toxicol. Appl. Pharmacol. 2006, 213(2):152-159.
50. Thom S.R., Tom S.N., Facp, Facpm, Stephen R.T., et al. Carbon Monoxide Pathophysiology and Treatment. Physiology and Medicine of Hyperbaric Oxygen Therapy 2008, 321-347. W.B. Saunders, Philadelphia. first ed.
51. Üzüm G., Sarper Diler A., Bahçekapili N., Ziya Ziylan Y. Erythropoietin prevents the increase in blood-brain barrier permeability during pentylentetrazol induced seizures. Life Sci. 2006, 78(22):2571-2576.
52. Vannucci S.J. Developmental expression of GLUT1 and GLUT3 glucose transporters in rat brain. J. Neurochem. 1994, 62(1):240-246.
53. Vos P.E., Lamers K.J.B., Hendriks J.C.M., Van Haaren M., Beems T., Zimmerman C., et al. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology 2004, 62(8):1303-1310.
54. Wang P., Zeng T., Zhang C.L., Gao X.C., Liu Z., Xie K.Q., et al. Lipid peroxidation was involved in the memory impairment of carbon monoxide-induced delayed neuron damage. Neurochem. Res. 2009, 34(7):1293-1298.
55. Wenger R.H. Mammalian oxygen sensing, signalling and gene regulation. J. Exp. Biol. 2000, 203(Pt 8):1253-1263.
56. Wenzel U., Daniel H. Early late apoptosis events in human transformed and non-transformed colonocytes are independent on intracellular acidification. Cell. Physiol. Biochem. 2004, 14(1-2):65-76.
57. Zhang G., Zhao Z., Gao L., Deng J., Wang B., Xu D., et al. Gypenoside attenuates white matter lesions induced by chronic cerebral hypoperfusion in rats. Pharmacol. Biochem. Behav. 2011, 99(1):42-51.